Avadel Pharmaceuticals Plc ADR (AVDL) Stock Price, Quote & News

Company Profile

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 a...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 353 1 901 5201

Website: www.avadel.com

Address:

10 Earlsfort Terrace, Dublin, Ireland

speed717 Jun. 26 at 4:47 PM

$AVDL Today is another example of why we need change in the board room. There is zero interest in this company. A company with a multi billion dollar market opportunity that nobody knows about because management can’t tell the story. Plain and simple. Enough is enough.

1 · Reply

PoorManRising Jun. 25 at 11:29 PM

$AVDL Still can’t figure out what the enormous volume was all about on June 20, 2025. Anybody know?

0 · Reply

Otus Jun. 24 at 11:28 PM

$AVDL any suggestions on an interim CEO if they actually replace Divis?

1 · Reply

Emsa Jun. 24 at 8:01 PM

$AVDL Vote no on all board members for failing to serve in the best interests of shareholders and enhance shareholder value. End fat salaries and option awards. Stop excessive compensation without results. Vote no to all !! It is time for a change

0 · Reply

speed717 Jun. 24 at 7:19 PM

$AVDL Regarding voting your proxies, it is my recommendation to Vote NO for all board members on the slate. This board has not done the job they have been hired to do, which is to enhance shareholder value and look out for shareholders interests. Divis is fat and happy with his $7MM annual salary and options awards, and the board as well is very quick to compensate themselves at our expense. This is a potential gold mine investment with the correct leadership. We have given them enough time and rope, it is now time to put the rope around their necks. VOTE NO.

1 · Reply

PoorManRising Jun. 24 at 7:12 PM

$AVDL https://x.com/ilzizzo/status/1937424006698926216?s=46&t=tCeRobHWSkSVGMhPDlFb3A

0 · Reply

Otus Jun. 24 at 3:55 PM

$AVDL god forbid the stock goes up two days in a row.

1 · Reply

Otus Jun. 24 at 2:33 PM

$AVDL proxies arrived this morning. I voted no on Divis.

2 · Reply

bernoneill Jun. 20 at 6:11 PM

$AVDL Interesting article: https://www.sciencealert.com/fda-approved-sleeping-pill-slows-alzheimers-tangles-in-pre-clinical-trial ""We have shown that lemborexant improves sleep and reduces abnormal tau, which appears to be a main driver of the neurological damage that we see in Alzheimer's and several related disorders," explains Washington University neurologist David Holtzman."

0 · Reply

Everest17 Jun. 19 at 11:39 AM

$AVDL I think this Board vote for July will be telling. A lot of upset retail and institutional investors.

1 · Reply

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Jun 5, 2025, 7:30 AM EDT - 21 days ago

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

May 29, 2025, 4:05 PM EDT - 4 weeks ago

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

May 29, 2025, 8:00 AM EDT - 4 weeks ago

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 15, 2025, 11:43 AM EDT - 6 weeks ago

Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'

May 13, 2025, 4:15 PM EDT - 6 weeks ago

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

May 13, 2025, 8:00 AM EDT - 6 weeks ago

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

May 7, 2025, 12:45 PM EDT - 7 weeks ago

Avadel Pharmaceuticals plc (AVDL) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:00 AM EDT - 7 weeks ago

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

May 6, 2025, 12:30 PM EDT - 7 weeks ago

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

Apr 30, 2025, 8:00 AM EDT - 2 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

Apr 17, 2025, 8:00 AM EDT - 2 months ago

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Apr 8, 2025, 1:30 PM EDT - 2 months ago

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 3 months ago

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Mar 25, 2025, 8:00 AM EDT - 3 months ago

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

Mar 5, 2025, 8:00 AM EST - 4 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Mar 3, 2025, 11:53 PM EST - 4 months ago

Avadel Pharmaceuticals plc (AVDL) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:00 AM EST - 4 months ago

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 4:05 PM EST - 4 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

Feb 24, 2025, 8:00 AM EST - 4 months ago

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

Feb 11, 2025, 6:08 PM EST - 4 months ago

Avadel Pharmaceuticals: Moving To A Speculative Buy

Feb 10, 2025, 9:00 AM EST - 4 months ago

ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors

Jan 13, 2025, 12:56 PM EST - 5 months ago

3 Oversold Biotech Names

FOLD JAZZ VKTX XBI

Jan 12, 2025, 3:26 AM EST - 5 months ago

Avadel Pharmaceuticals: Patient Attrition Weighs On 2025 Outlook

Jan 8, 2025, 4:15 PM EST - 6 months ago

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

Jan 3, 2025, 8:00 AM EST - 6 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8

Nov 13, 2024, 8:00 AM EST - 8 months ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Nov 12, 2024, 3:19 PM EST - 8 months ago

Avadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:00 AM EDT - 8 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

Oct 17, 2024, 10:03 AM EDT - 9 months ago

US FDA expands approval for Avadel's sleep disorder drug

Oct 17, 2024, 9:41 AM EDT - 9 months ago

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

Sep 3, 2024, 8:30 AM EDT - 10 months ago

Avadel Pharmaceuticals: The Oxybate War With Jazz Waxes On

Sep 3, 2024, 8:00 AM EDT - 10 months ago

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

Aug 9, 2024, 12:27 PM EDT - 11 months ago

Avadel Pharmaceuticals plc (AVDL) Q2 2024 Earnings Call Transcript

Jun 27, 2024, 4:05 PM EDT - 1 year ago

Avadel Pharmaceuticals to Join Russell 3000® Index

May 22, 2024, 8:00 AM EDT - 1 year ago

Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

May 21, 2024, 7:00 AM EDT - 1 year ago

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

May 8, 2024, 7:00 AM EDT - 1 year ago

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

May 1, 2024, 8:00 AM EDT - 1 year ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

Apr 2, 2024, 3:40 AM EDT - 1 year ago

Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Mar 4, 2024, 3:37 PM EST - 1 year ago

Avadel Pharmaceuticals Issues Statement On Patent Litigation

Mar 4, 2024, 10:43 AM EST - 1 year ago

Avadel Pharmaceuticals plc (AVDL) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 6:30 AM EST - 1 year ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Jan 28, 2024, 2:56 AM EST - 1 year ago

Avadel Pharmaceuticals: Strong Launch Of Lumryz With A Legal Risk Backdrop

Jan 11, 2024, 11:31 AM EST - 1 year ago

Avadel May Continue To Outperform With Positive Launch Momentum

Nov 14, 2023, 4:00 PM EST - 1 year ago

Avadel: Lumryz Lights Up The Oxybate Market, Maintaining Buy Rating

Nov 8, 2023, 1:48 PM EST - 1 year ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 7:00 AM EST - 1 year ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Oct 20, 2023, 8:00 AM EDT - 1 year ago

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023

speed717 Jun. 26 at 4:47 PM

1 · Reply

PoorManRising Jun. 25 at 11:29 PM

$AVDL Still can’t figure out what the enormous volume was all about on June 20, 2025. Anybody know?

0 · Reply

Otus Jun. 24 at 11:28 PM

$AVDL any suggestions on an interim CEO if they actually replace Divis?

1 · Reply

Emsa Jun. 24 at 8:01 PM

0 · Reply

speed717 Jun. 24 at 7:19 PM

1 · Reply

PoorManRising Jun. 24 at 7:12 PM

$AVDL https://x.com/ilzizzo/status/1937424006698926216?s=46&t=tCeRobHWSkSVGMhPDlFb3A

0 · Reply

Otus Jun. 24 at 3:55 PM

$AVDL god forbid the stock goes up two days in a row.

1 · Reply

Otus Jun. 24 at 2:33 PM

$AVDL proxies arrived this morning. I voted no on Divis.

2 · Reply

bernoneill Jun. 20 at 6:11 PM

0 · Reply

Everest17 Jun. 19 at 11:39 AM

$AVDL I think this Board vote for July will be telling. A lot of upset retail and institutional investors.

1 · Reply

Sunny530 Jun. 18 at 12:12 AM

$AVDL this should have been to 15 by Friday

1 · Reply

Lukumon Jun. 17 at 4:16 PM

$ARDX $AVDL Susan new company.

1 · Reply

speed717 Jun. 17 at 2:20 PM

$AVDL I have been holding this for awhile, but it is time to share. The below photo represents a deck from the AVDL website showing that they have a 1x nightly , NO SALT product that completed Ph2. They have since removed this and gone back to saying they have 1x low salt in development. I believe they have been collaborating for a while on this product and created the deck in anticipation of announcement. Jazz killer for sure, and for a new indication…..Parkinson’s!!!!!! Management has been keeping this from investors.

2 · Reply

LewisDaKat Jun. 16 at 10:55 PM

News Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://marketwirenews.com/news-releases/avadel-announces-grant-of-inducement-awards-under-na-8719673881620949.html $AVDL

0 · Reply

speed717 Jun. 16 at 12:51 PM

$AVDL Down pre market today. Checking all sources I see or hear nothing. Any clues anyone?

1 · Reply

NewbieMe21 Jun. 12 at 9:04 PM

$AVDL anyone else notice daily 100-200k purchases at close the last week? Try to nest down then pick up at close mentality?

2 · Reply

speed717 Jun. 12 at 7:25 PM

$AVDL Sleep conference came and went and not a peep from the worlds worst management team. In the hands of capable managers, we would be in the 20’s , instead we sit at same price as 5 years ago. Management will tell you how successful they have been launching Lumryz. You get a report card everyday in the form of your share price and AVDL management gets a fucking F!!!!

2 · Reply

Breakfast_Stouts Jun. 12 at 5:27 PM

$AVDL ouch. Lost the momentum

0 · Reply

Zeyas Jun. 10 at 12:57 PM

$AVDL

0 · Reply

Breakfast_Stouts Jun. 9 at 11:44 PM

$AVDL well the volume showed up today

0 · Reply

Otus Jun. 6 at 4:34 PM

$AVDL I’m thinking if we can get over the wall that is 10, price momentum will take us to a more reasonable valuation.

2 · Reply

Rockstar201 Jun. 5 at 5:37 PM

$AVDL weird price action today. Hopefully I’ll clear some day trades tomorrow and buy more

1 · Reply

Market Cap	928.69M
Revenue (ttm)	169.12M
Net Income (ttm)	-48.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	72.21
Profit Margin	-28.87%
Debt to Equity Ratio	0.00

Volume	680,000
Avg Vol	1,379,078
Day's Range	N/A - N/A
Shares Out	96.74M
Stochastic %K	50%
Beta	1.45
Analysts	Strong Sell
Price Target	$17.00